About Us
Our Mission
- Improve health outcomes by increasing the quality and availability of difficult-to-procure transfusable blood products
- Create an emotional connection between donors and our shared mission to save lives
- Foster an enduring relationship with our hospital customers and provide them an unprecedented level of service quality
- Serve as a leader in the efforts to modernize and stabilize the blood industry, creating pertinent safeguards in times of supply chain disruption

Our Process
We maintain
We produce
We believe
We connect
We value
the non-profit blood banking community and the critical role it plays in sustaining the nation’s blood supply
Our Team

Vijai Mohan

Kris Jonas

Philip Spinella, MD

Drew Schneider

Jason Swenson
Board of Directors
Laurence Cooper, MD PhD – CEO, Ziopharm Oncology, Inc.
Vijai Mohan – Founder and CEO, STS
Carol Moore – SVP of Regulatory and Quality, Cerus Corporation
George “Bud” Scholl – CEO OneBlood, Inc.
Senior Advisors
Andrew Heaton, MBBS – Former Chief Medical Officer, Novartis Diagnostics
John Roback, MD PhD – Department of Pathology and Laboratory Medicine, Emory University School of Medicine
Susan Shurin, MD – Former Deputy Director of National Heart, Lung, and Blood Institute
Our Partners
Our Affiliations
STS is a member of both the American Association of Blood Banks (AABB) and the Plasma Protein Therapeutics Association (PPTA)